Live Breaking News & Updates on Fate Therapeutics Daily
Stay updated with breaking news from Fate therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating)’s share price fell 6.4% during trading on Thursday . The company traded as low as $5.05 and last traded at $5.12. 514,360 shares traded hands during trading, a decline of 84% from the average session volume of 3,163,753 shares. The stock had previously closed at $5.47. Analysts Set […] ....
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating) have been given an average rating of “Hold” by the twenty-two ratings firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating on […] ....
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating) have been given a consensus rating of “Hold” by the twenty-three research firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and five have issued a buy recommendation on the […] ....
Fate Therapeutics (NASDAQ:FATE – Get Rating) had its target price lowered by Stifel Nicolaus from $5.30 to $5.00 in a research report sent to investors on Thursday, The Fly reports. Several other analysts also recently weighed in on the stock. HC Wainwright downgraded shares of Fate Therapeutics from a buy rating to a neutral rating […] ....
Fate Therapeutics (NASDAQ:FATE – Get Rating) had its target price lowered by Cantor Fitzgerald from $8.00 to $5.00 in a report published on Thursday, The Fly reports. FATE has been the topic of a number of other reports. Morgan Stanley reduced their price objective on shares of Fate Therapeutics from $35.00 to $8.00 and set […] ....